Sodoma Andrej M, Pellegrini James R, Greenberg Samuel, Sodoma Andrej, Munshi Rezwan, Pellegrini Richard G, Singh Jaspreet
Internal Medicine, South Shore University Hospital, Bay Shore, USA.
Internal Medicine, Nassau University Medical Center, East Meadow, USA.
Cureus. 2024 Dec 16;16(12):e75820. doi: 10.7759/cureus.75820. eCollection 2024 Dec.
Liver transplant (LT) patients face various challenges, including an increased risk of coronary artery disease (CAD) for a variety of reasons, with 70% of LT recipients having one cardiovascular event. Coronary artery bypass grafting (CABG) remains one of the most commonly performed major surgical procedures in the United States, with 20-30% of LT patients requiring a CABG. Many studies have analyzed when to perform a CABG and CAD workup pre-LT, but this population remains a problem. The patient population is challenging to study due to their rarity and complexity. Our study aimed to compile many patients through the National Inpatient Sample (NIS) database to gauge the outcomes of CABG in patients with and without a history of LT. Methods: Patients who underwent CABG with or without a history of LT were selected from the NIS from 2008 to 2020. The International Classification of Diseases (ICD) 9 and 10 codes were used to identify suitable records. Primary outcomes of interest were all-cause hospital mortality, shock, acute myocardial infarction, acute kidney injury (AKI), and a composite of these. Secondary outcomes included length of stay and total charges. Results: A weighted total of 2,407,349 CABG hospitalizations were included in this study. Of these, 1,833 had a history of LT. Overall, patients with a history of LT were more likely to be younger (65.16 vs. 66.16; p<0.001), male (81.6% vs. 73.66%; p<0.001), and more complex (Charlson Comorbidity Index (CCI) 5.89 vs. 4.16; p<0.001) than patients without a history of LT. Patients with a history of LT also had higher rates of diabetes mellitus type 2 (57.02% vs. 43.39%; p<0.001), end-stage renal disease (11.21% vs. 2.95%; p<0.001), and gastroesophageal reflux disease (GERD) (28.39% vs. 21.26%; p<0.001). CABG patients with a history of LT were less likely, however, to have hyperlipidemia (56.72% vs. 74.26%; p<0.001), hypertension (25.95% vs. 58.45%; p<0.001), obesity (19% vs. 23.42%; p=0.046), a history of smoking (12.06% vs. 18.66%; p<0.01), or alcohol use disorder (9.04% vs. 13.44%; p=0.017). We found that patients admitted for CABG with a history of LT had significantly higher adjusted odds of mortality (OR 1.84; p<0.01), AKI (OR 2.65; p<0.001), and composite outcome (OR 2.04; p<0.001). They also experienced a longer length of stay (1.7 days; p=0.02) and greater hospital charges ($26,761; p=0.029).
We found that CABG patients with a history of LT had nearly twofold higher odds of mortality, nearly threefold higher odds of AKI, and twofold higher odds of composite outcomes than CABG patients without LT. This corresponded to longer lengths of stay and increased hospital charges. Patients should require lower thresholds for left heart catheterization and more strict CAD testing before an LT due to the increased risk of adverse outcomes with the current standard of care.
肝移植(LT)患者面临各种挑战,包括因多种原因导致的冠状动脉疾病(CAD)风险增加,70%的LT受者会发生一次心血管事件。冠状动脉旁路移植术(CABG)仍然是美国最常进行的主要外科手术之一,20%-30%的LT患者需要进行CABG。许多研究分析了LT前何时进行CABG和CAD检查,但这一人群仍然是个问题。由于其罕见性和复杂性,该患者群体的研究具有挑战性。我们的研究旨在通过国家住院样本(NIS)数据库汇总众多患者,以评估有或无LT病史患者的CABG结局。
从2008年至2020年的NIS中选择有或无LT病史且接受CABG的患者。使用国际疾病分类(ICD)9和10编码来识别合适的记录。感兴趣的主要结局是全因住院死亡率、休克、急性心肌梗死、急性肾损伤(AKI)以及这些情况的综合。次要结局包括住院时间和总费用。
本研究共纳入加权后的2407349例CABG住院患者。其中,1833例有LT病史。总体而言,有LT病史的患者比无LT病史的患者更年轻(65.16岁对66.16岁;p<0.001)、男性比例更高(81.6%对73.66%;p<0.001)且病情更复杂(Charlson合并症指数(CCI)5.89对4.16;p<0.001)。有LT病史的患者2型糖尿病(57.02%对43.39%;p<0.001)、终末期肾病(11.21%对2.95%;p<0.001)和胃食管反流病(GERD)(28.39%对21.26%;p<0.001)的发生率也更高。然而,有LT病史的CABG患者患高脂血症(56.72%对74.26%;p<0.001)、高血压(25.95%对58.45%;p<0.001)、肥胖(19%对23.42%;p=0.046)、吸烟史(12.06%对18.66%;p<0.01)或酒精使用障碍(9.04%对13.44%;p=0.017)的可能性较小。我们发现,因CABG入院且有LT病史的患者调整后的死亡几率(OR 为1.84;p<0.01)、AKI几率(OR 为2.65;p<0.001)和综合结局几率(OR 为2.04;p<0.001)显著更高。他们的住院时间也更长(1.7天;p=0.02),住院费用更高(26761美元;p=0.029)。
我们发现,有LT病史的CABG患者的死亡几率比无LT病史的CABG患者高出近两倍,AKI几率高出近三倍,综合结局几率高出两倍。这与更长的住院时间和更高的住院费用相对应。由于当前护理标准下不良结局风险增加,患者在LT前应降低左心导管插入术的阈值,并进行更严格的CAD检测。